Seattle Genetics Announces Executive Promotions and Management Addition

Published February 11, 2014

Seattle Genetics Announces Executive Promotions and Management Addition
David brings more than 20 years of leadership experience in the biopharmaceutical industry, including a background in strategic portfolio and program management." Chris Boerner, Ph.D., has been promoted to Executive Vice President … Dr. Boerner … Read more on Wall Street Journal

Synthetic Biologics Announces Rhonda Voskuhl, M.D., to Present Trimesta …
Lead Principal investigator, Rhonda Voskuhl, M.D., Professor, Department of Neurology, Jack H. Skirball Chair in Multiple Sclerosis Research and Director, Multiple Sclerosis Program at University of California, Los Angeles (UCLA) School of Medicine … Read more on PR Newswire (press release)

Chief Lansdowne's fatally flawed fix for drug abuse
The money saved, which they estimate at $ 150 million to $ 200 million a year, would be earmarked for drug treatment and mental health programs, crime prevention programs in schools and a fund for victims of trauma. If cleared by the state for … Read more on U-T San Diego